-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Post-traumatic stress disorder (PTSD) is a common chronic mental illness that occurs after exposure to a traumatic event
Anger treatment is recommended as part of the treatment of post-traumatic stress disorder
This article reports a follow-up analysis of the impact of the iTBS regimen on self-reported anger and related clinical characteristics
Average reported anger (DAR score) of individuals who received four weeks of iTBS (individuals randomly assigned to active iTBS during the double-blind period) and individuals who received two weeks of iTBS (individuals who were initially randomly assigned to false stimuli)
After the first week, in the double-blind phase, subjects who randomly received the active stimulus reported that anger was significantly reduced compared to the fake stimulus (p=0.
An exploratory focus of this research is to assess the relationship between changes in anger and PTSD and depressive symptoms, as well as changes in sleep quality
In short, iTBS may reduce the anger of veterans with post-traumatic stress disorder
Leave a message here